Cargando…
Time to Start Calling Things by Their Own Names? The Case for Antiseizure Medicines
Medicines currently used in the management of epilepsy have been developed to suppress seizures, and they have no known impact on the underlying disease. Using the term “antiepileptic” to describe these compounds is misleading because it suggests an action on the epilepsy itself. Pharmacological age...
Autores principales: | French, Jacqueline A., Perucca, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160876/ https://www.ncbi.nlm.nih.gov/pubmed/32077329 http://dx.doi.org/10.1177/1535759720905516 |
Ejemplares similares
-
Measure for Measure: Measuring the Usefulness of Measuring Antiseizure
Medication Levels
por: Faught, Edward
Publicado: (2020) -
Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
por: Vossler, David G.
Publicado: (2022) -
Putting a Band-Aid on a Broken Leg: Antiseizure Medications Are Inferior to Immune Therapies in Autoimmune Epilepsy
por: Gaspard, Nicolas
Publicado: (2019) -
Sometimes, More Is More: Antiseizure Medication polytherapy Is Associated With Decreased SUDEP Risk
por: Lee, Jong Woo
Publicado: (2021) -
Exploring the Cognitive Outcomes of Children Prenatally Exposed to
Antiseizure Medications: Mind the Lab
por: Eyal, Sara
Publicado: (2021)